Zobrazeno 1 - 3
of 3
pro vyhledávání: '"P. A. S. Fishkin"'
Autor:
Ajay Major, Justin Kline, Theodore G. Karrison, Paul A. S. Fishkin, Amy S. Kimball, Adam M. Petrich, Sreenivasa Nattam, Krishna Rao, Bethany G. Sleckman, Kenneth Cohen, Koen van Besien, Aaron P. Rapoport, Sonali M. Smith
Publikováno v:
Haematologica, Vol 107, Iss 7 (2021)
The PI3K/Akt/mTOR (PAM) axis is constitutively activated in multiple lymphoma subtypes and is a promising therapeutic target. The mTOR inhibitor temsirolimus (TEM) and the immunomodulatory agent lenalidomide (LEN) have overlapping effects within the
Externí odkaz:
https://doaj.org/article/da69c238a67c488eac97c5b0995a9e46
Autor:
S. Krauss, Thomas E. Lad, Harvey M. Golomb, A. Klepsch, P. A. S. Fishkin, R. H. Ansari, D. F. Sciortino, Everett E. Vokes, Mark J. Ratain, G. A. Masters, Philip C. Hoffman
Publikováno v:
Annals of Oncology. 9:1085-1090
Summary Background 9-Aminocamptothecin (9-AC) is a synthetic analogue of camptothecin. Phase I studies, identified the maximum tolerated dose as 1416 μg/m2/day × 3 as continuous intravenous infusion (CVI) with dose-limiting neutropenia. Patients an
Autor:
T. Lad, Harvey M. Golomb, P. A. S. Fishkin, Philip C. Hoffman, M. Ratain, Rafat Ansari, Gregory A. Masters, D. Sciortino, Everett E. Vokes, Stuart A. Krauss, A. Klepsch, H. Minami
Publikováno v:
Lung Cancer. 18:4